Terns Pharmaceuticals Inc. (TERN) Fundamentals

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.
SHARE INFORMATION
Market Cap$ 54,856,018
Shares Outstanding25,279,271
Float11,230,383
Percent Float44.43%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 1,000,000
Latest Fiscal EPS$ -2.35
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions116
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months230,226
Institutional Holdings Percent70.0%
Institutional Sold Previous 3 Months3,580,311
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months518,968
Insider Holdings Percent1.2
Insider Sold Previous 3 Months-
Insider Shares Owned308,682
TRADING INFO
52 Week High$ 13.77
52 Week Low$ 1.45
52 Week High Change$ -74.83
21 Day Moving Average$ 2.3162
21 Day Extended Moving Average$ 2.1963
50 Day Moving Average$ 2.157
50 Day Extended Moving Average$ 2.2302
200 Day Moving Average$ 4.2355
200 Day Extended Moving Average$ 4.6447
10 Day Average Volume57,367
20 Day Average Volume54,790
30 Day Average Volume108,837
50 Day Average Volume182,280
Alpha-0.091193
Beta0.6118
Standard Deviation0.312263
R20.010300
7 Day Price Change$ 0.04
7 Day Percent Change1.88%
21 Day Price Change$ -0.37
21 Day Percent Change-14.57%
30 Day Price Change$ -0.26
30 Day Percent Change-10.7%
Month to Date Price Change$ 0.04
Month to Date Percent Change1.88%
Quarter to Date Price Change$ -0.31
Quarter to Date Percent Change-12.5%
180 Day Price Change$ -2.08
180 Day Percent Change-48.94%
200 Day Price Change$ -3.68
200 Day Percent Change-62.91%
Year to Date Price Change$ -4.90
Year to Date Percent Change-69.31%

Terns Pharmaceuticals Inc. (TERN) Key Ratios

PROFITABILITY
EBIT Margin-5,038.9%
EBITDA Margin-4,977.1%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 1,000,000
Revenue Per Share$ 0.0396
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.40
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio25.00
Leverage Ratio1.10
Quick Ratio24.50
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-1.10
Enterprise Value$ -94,827,982
Price to Sales54.856
Price to Free Cash-1.70
PE High Last 5 Years0.00
Price To Book0.40
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.20
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-29.35
Return on Equity-30.84
Return on Capital-29.68

Terns Pharmaceuticals Inc. (TERN) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOSenthil Sundaram
Emplyoees41
Last AuditUQ
CIK0001831363
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1065 East Hillsdale Boulevard
Suite 100
Foster, CA 94404
Websitehttps://www.ternspharma.com
Facsimile+1 650 275-4395
Telephone+1 650 525-5535
Emailinvestors@ternspharma.com


Your Recent History
NASDAQ
TERN
Terns Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.